Goldman Sachs on Cardiovascular Devices: LVAD Assets Look Mispriced; Upgrading THOR, Initiating HTWR
Go back to Goldman Sachs on Cardiovascular Devices: LVAD Assets Look Mispriced; Upgrading THOR, Initiating HTWR| Heartware International, Inc. (NASDAQ: HTWR) | Delayed: 57.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.98 | 52 Week High | $87.38 | |||
| Open | $0.20 | 52 Week Low | $25.02 | |||
| Day High | $57.98 | P/E | N/A | |||
| Day Low | $57.98 | EPS | $-3.81 | |||
| Volume | 2,500 | |||||
| Thoratec Corp (NYSE: THOR) | Delayed: 26.31 +0.02 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.29 | 52 Week High | $63.51 | |||
| Open | $26.35 | 52 Week Low | $25.04 | |||
| Day High | $28.99 | P/E | 20.88 | |||
| Day Low | $26.31 | EPS | $1.26 | |||
| Volume | 33,111 | |||||
